BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Kidney tumors AND EGFR, mENA, 1956, ENSG00000146648, P00533, ERBB1, ERBB AND Staging
17 results:

  • 1. Gene mutation profiling and clinical significances in patients with renal cell carcinoma.
    Wang Y; He P; Zhou X; Wang C; Fu J; Zhang D; Liao D; Zhou Z; Wu C; Gong W
    Clinics (Sao Paulo); 2023; 78():100259. PubMed ID: 37515929
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Progression of Chronic kidney Disease Following Radical and Partial Nephrectomy.
    Britton CJ; Sharma V; Lohse CM; Lieske JC; Nichols PE; Khanna A; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH; Potretzke AM
    Urology; 2022 Nov; 169():125-133. PubMed ID: 35878813
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Delineating and sparing functional nephrons for radiotherapy in the case of lymphoma with polycystic kidney disease.
    Gurusamy VM; Chandramouli SH; Usman M; Divakar SR; Hammoud RW; Al-Hammadi N
    Cancer Treat Res Commun; 2022; 31():100566. PubMed ID: 35487053
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. kidney Autotransplantation in a 78-Year-Old Man with Proximal Ureteral Urothelial Carcinoma after Living Donor Nephrectomy.
    Wacker C; Schiffer M; Richterstetter M; Opgenoorth M; Apel H
    Urol Int; 2020; 104(11-12):994-996. PubMed ID: 32731222
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Text mining in a literature review of urothelial cancer using topic model.
    Lin HJ; Sheu PC; Tsai JJP; Wang CCN; Chou CY
    BMC Cancer; 2020 May; 20(1):462. PubMed ID: 32448176
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Emerging concepts and spectrum of renal injury following Intravesical BCG for non-muscle invasive bladder cancer.
    Mohammed A; Arastu Z
    BMC Urol; 2017 Dec; 17(1):114. PubMed ID: 29212486
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Association of preoperative hypoalbuminemia with postoperative acute kidney injury in patients undergoing brain tumor surgery: a retrospective study.
    Kim K; Bang JY; Kim SO; Kim S; Kim JU; Song JG
    J Neurosurg; 2018 Apr; 128(4):1115-1122. PubMed ID: 28474996
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. kidney disease progression in patients of upper tract urothelial carcinoma following unilateral radical nephroureterectomy.
    Lee KH; Chen YT; Chung HJ; Liu JS; Hsu CC; Tarng DC
    Ren Fail; 2016; 38(1):77-83. PubMed ID: 26513686
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Increasing volume of non-neoplastic parenchyma in partial nephrectomy specimens is associated with chronic kidney disease upstaging.
    Kotamarti S; Rothberg MB; Danzig MR; Levinson J; Saad S; Korets R; McKiernan JM; Badani KK
    Clin Genitourin Cancer; 2015 Jun; 13(3):239-43. PubMed ID: 25497585
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Follow-up for Clinically Localized Renal Neoplasms: AUA Guideline.
    Donat SM; Diaz M; Bishoff JT; Coleman JA; Dahm P; Derweesh IH; Herrell SD; Hilton S; Jonasch E; Lin DW; Reuter VE; Chang SS
    J Urol; 2013 Aug; 190(2):407-16. PubMed ID: 23665399
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Selecting a prognostic renal surrogate for patients with hepatocellular carcinoma undergoing transarterial chemoembolization.
    Lee YH; Hsu CY; Huang YH; Su CW; Lin HC; Lee RC; Chiou YY; Huo TI; Lee SD
    J Gastroenterol Hepatol; 2012 Oct; 27(10):1581-8. PubMed ID: 22497632
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Nephron-sparing surgery for pathological stage T3b renal cell carcinoma confined to the renal vein.
    Kolla SB; Ercole C; Spiess PE; Pow-Sang JM; Sexton WJ
    BJU Int; 2010 Nov; 106(10):1494-8. PubMed ID: 20230378
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Prognostic significance of Id-1 and its association with egfr in renal cell cancer.
    Li X; Zhang Z; Xin D; Chua CW; Wong YC; Leung SC; Na Y; Wang X
    Histopathology; 2007 Mar; 50(4):484-90. PubMed ID: 17448024
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Frequency and clinicopathologic correlates of erbb1, erbb2, and erbb3 immunoreactivity in urothelial tumors of upper urinary tract.
    Tsai YS; Tzai TS; Chow NH; Wu CL
    Urology; 2005 Dec; 66(6):1197-202. PubMed ID: 16360440
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. HER-2/neu is expressed in human renal cell carcinoma at heterogeneous levels independently of tumor grading and staging and can be recognized by HLA-A2.1-restricted cytotoxic T lymphocytes.
    Seliger B; Rongcun Y; Atkins D; Hammers S; Huber C; Störkel S; Kiessling R
    Int J Cancer; 2000 Aug; 87(3):349-59. PubMed ID: 10897039
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Flow cytometric and immunohistochemical correlations in high incidence human solid tumors.
    Danesi DT; Spanò M; Antonini F; Altavista P; Catalano P; Cordelli E; Pasqualetti P; Santacroce C; Toscano MG; Mecozzi A; Fabiano A
    Tumori; 1997; 83(3):689-97. PubMed ID: 9267490
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Classification (staging) of renal parenchymal tumours.
    Petković SD
    Int Urol Nephrol; 1978; 10(3):167-84. PubMed ID: 689813
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.